U.S. Facial Injectable Market Size & Outlook, 2023-2030
U.S. facial injectable market, 2018-2030 (US$M)
Related Markets
U.S. facial injectable market highlights
- The U.S. facial injectable market generated a revenue of USD 4,692.0 million in 2023 and is expected to reach USD 8,913.6 million by 2030.
- The U.S. market is expected to grow at a CAGR of 9.6% from 2024 to 2030.
- In terms of segment, botulinum toxin type a was the largest revenue generating product in 2023.
- HA is the most lucrative product segment registering the fastest growth during the forecast period.
Facial injectable market data book summary
| Market revenue in 2023 | USD 4,692.0 million |
| Market revenue in 2030 | USD 8,913.6 million |
| Growth rate | 9.6% (CAGR from 2023 to 2030) |
| Largest segment | Botulinum toxin type a |
| Fastest growing segment | HA |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Collagen, Botulinum Toxin Type A, HA, CaHA, Polymer Fillers |
| Key market players worldwide | Ipsen SA, AbbVie Inc, Medytox, Revance Therapeutics Inc, Galderma Group AG Registered Shares, Sinclair Pharma plc, Merz Pharma |
Other key industry trends
- In terms of revenue, U.S. accounted for 39.5% of the global facial injectable market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. facial injectable market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 8,913.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Facial Injectable Market Scope
Facial Injectable Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. facial injectable market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to facial injectable market will help companies and investors design strategic landscapes.
Botulinum toxin type a was the largest segment with a revenue share of 55.5% in 2023. Horizon Databook has segmented the U.S. facial injectable market based on collagen, botulinum toxin type a, ha, caha, polymer fillers covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. held 86.93% share of North America facial injectables market. According to a report by the International Society of Aesthetic Plastic Surgery (ISAPS), in 2022, nearly 4,556,970 nonsurgical injectable procedures were performed in the U.S., of which 3,945,282 procedures involved Botox fillers and 521,169 involved Hyaluronic Acid (HA) fillers.
An increase in the number of cosmetic procedures is expected to boost the U.S. facial injectable market over the forecast period. The growing geriatric population in the U.S., which is susceptible to skin imperfections or diseases, is expected to increase the demand for cosmetic procedures, thereby significantly contributing to the market growth over the forecast period.
Moreover, according to a Population Reference Bureau article, the geriatric population in the region is anticipated to increase by 69% from 2020 to 2060. Furthermore, the country has the highest number of plastic surgeons, which is expected to boost the market growth.
Reasons to subscribe to U.S. facial injectable market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. facial injectable market databook
-
Our clientele includes a mix of facial injectable market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. facial injectable market , including forecasts for subscribers. This country databook contains high-level insights into U.S. facial injectable market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. facial injectable market size, by product, 2018-2030 (US$M)
U.S. Facial Injectable Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
